NCT07833124

Brief Summary

This retrospective study combine radiomics and deep learning models to predict malignancy in Bosniak II-III cystic renal masses, aiming for improving preoperative risk assessment and reducing unnecessary surgery for benign lesions and avoiding delayed treatment of malignant disease. The main question it aims to answer is:

  • How to specially predict malignancy in Bosniak II-III cystic renal masses? The investigators retrospectively included patients diagnosed with Bosniak II-III cystic renal masses based on preoperative contrast-enhanced CT.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
223

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 10, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 28, 2024

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

September 16, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 22, 2026

Completed
Last Updated

September 22, 2026

Status Verified

September 1, 2026

Enrollment Period

4 months

First QC Date

September 16, 2026

Last Update Submit

September 16, 2026

Conditions

Keywords

Convolutional Neural NetworksDeep LearningTomography, X-Ray ComputedKidney Diseases, Cystic

Outcome Measures

Primary Outcomes (1)

  • the area under the receiver operating characteristic curve

    The area under the receiver operating characteristic curve measures the overall ability of a binary classifier to distinguish between positive and negative classes, with values ranging from 0.5 (random guessing) to 1.0 (perfect classification).

    preoperatively

Secondary Outcomes (3)

  • sensitivity

    preoperatively

  • specificity

    preoperatively

  • balanced accuracy

    preoperatively

Study Arms (2)

Benign

Patients who were istopathologically diagnosed benign renal cysts

Malignant

Patients who were istopathologically diagnosed malignant renal cysts

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population includes patients diagnosed with renal cyst in the participated centers. Clinical and imaging data were retrospectively collected from medical records, including demographic characteristics (age, gender, BMI), cyst characters(size, loction, aterality, number of septa, septal thickness, wall thickness, presence of calcification, enhancement pattern, mural nodules, and Bosniak classification). Histopathological findings were also collected when available and were used as the reference standard for lesions that underwent surgical resection.

You may qualify if:

  • diagnosed with cystic renal masses

You may not qualify if:

  • olid portion \> 25%;
  • polycystic kidney disease;
  • maximum diameter\<1cm;
  • Von Hippel-Lindau syndrome;
  • without complete CT examination or histopathology-proven CRMs;
  • poor image quality;
  • Bosniak I and Bosniak IV masses.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Hospital Fudan University, Location: 180th Fenglin Road, Xuhui District, Shanghai, China

Shanghai, Shanghai Municipality, 200030, China

Location

MeSH Terms

Conditions

Kidney Diseases, Cystic

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 16, 2026

First Posted

September 22, 2026

Study Start

September 10, 2024

Primary Completion

December 28, 2024

Study Completion

August 31, 2026

Last Updated

September 22, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share

Clinical data and extracted radiomics feature data, excluding patient information.

Shared Documents
STUDY PROTOCOL
Time Frame
Within six months after publication in the journal.
Access Criteria
The data supporting this study are available from the enrolled institutions, but restrictions apply to their availability due to privacy reasons. Data can be accessed upon reasonable request from the corresponding author.

Locations